John Parkinson

A telephone survey confirms people are dealing with these issues and suggests it may be an early bellwether to providers and patients alike.

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

the company announced it COVID-19 medication is looking to address viral replication and uncontrolled inflammatory response.

A modeling study from the UK reinforces how the transmission rates from infected people can be lowered using a variety of well-known strategies.

New study shows reduced deaths by one-third in ventilated patients, and one-fifth in patients receiving oxygen

In a modeling study, an estimated 1.7 billion people are at an increased risk of the virus, but a much smaller percentage would require hospitalization.

In a controlled environment, investigators found sunlight affected the decay rate of the virus.

During the spring COVID-19 outbreak, an examination of Swiss people in Geneva shows only a small amount of the population with IgG antibodies.

In a very small international study using the antiviral, 68% of hospitalized patients on ventilators or oxygen showed improvement.

As the lockdown ends, the NIAID director talks the continued need for social distancing, vaccines, and emerging therapies.

The antibacterial is efficacious in a majority of patients in a small study.

Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.

Early administration of such therapies in this patient group not shown to help mortality rates.

An assessment of 21 pediatric cases leads France investigators to believe development is due to post-viral immunological reactions.